| The entry of nanoparticles into solid tumours S Sindhwani, AM Syed, J Ngai, BR Kingston, L Maiorino, J Rothschild, ... Nature materials 19 (5), 566-575, 2020 | 1177 | 2020 |
| An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells D Jia, L Li, S Andrew, D Allan, X Li, J Lee, G Ji, Z Yao, S Gadde, D Figeys, ... Cell death & disease 8 (7), e2932-e2932, 2017 | 88 | 2017 |
| Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states A Sulaiman, S McGarry, L Li, D Jia, S Ooi, C Addison, J Dimitroulakos, ... Molecular oncology 12 (4), 423-440, 2018 | 66 | 2018 |
| Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors A Sulaiman, L Wang Oncotarget 8 (68), 113269, 2017 | 50 | 2017 |
| Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells A Sulaiman, S McGarry, KM Lam, S El-Sahli, J Chambers, S Kaczmarek, ... Cell death & disease 9 (8), 815, 2018 | 44 | 2018 |
| Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression A Sulaiman, Z Yao, L Wang Journal of biomedical research 32 (2), 81, 2018 | 40 | 2018 |
| CSCs in breast cancer—one size does not fit all: Therapeutic advances in targeting heterogeneous epithelial and mesenchymal CSCs A Sulaiman, S McGarry, X Han, S Liu, L Wang Cancers 11 (8), 1128, 2019 | 36 | 2019 |
| Both bulk and cancer stem cell subpopulations in triple‐negative breast cancer are susceptible to Wnt, HDAC, and ER α coinhibition A Sulaiman, B Sulaiman, L Khouri, S McGarry, C Nessim, A Arnaout, X Li, ... FEBS letters 590 (24), 4606-4616, 2016 | 32 | 2016 |
| A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature S El-Sahli, K Hua, A Sulaiman, J Chambers, L Li, E Farah, S McGarry, ... Cell death & disease 12 (1), 8, 2021 | 29 | 2021 |
| Co-targeting bulk tumor and CSCs in clinically translatable TNBC patient-derived xenografts via combination nanotherapy A Sulaiman, S McGarry, S El-Sahli, L Li, J Chambers, A Phan, M Cote, ... Molecular Cancer Therapeutics 18 (10), 1755-1764, 2019 | 19 | 2019 |
| Clinically translatable approaches of inhibiting TGF-β to target cancer stem cells in TNBC A Sulaiman, S McGarry, SC Chilumula, R Kandunuri, V Vinod Biomedicines 9 (10), 1386, 2021 | 16 | 2021 |
| Targeting hypoxia sensitizes TNBC to cisplatin and promotes inhibition of both bulk and cancer stem cells A Sulaiman, S McGarry, J Chambers, E Al-Kadi, A Phan, L Li, K Mediratta, ... International Journal of Molecular Sciences 21 (16), 5788, 2020 | 15 | 2020 |
| E-cadherin adhesion-mediated Wnt activation for mesoderm specification in human embryonic stem cells needs a soft mattress A Sulaiman, L Li, L Wang Stem Cell Investigation 3, 2016 | 2 | 2016 |
| At the Intersection of Cardiology and Oncology: TGFβ as a Clinically Translatable Therapy for TNBC Treatment and as a Major Regulator of Post-Chemotherapy Cardiomyopathy A Sulaiman, J Chambers, SC Chilumula, V Vinod, R Kandunuri, ... Cancers 14 (6), 1577, 2022 | 1 | 2022 |
| Nanoparticles Loaded with Wnt and YAP/Mevalonate Inhibitors in Combination with Paclitaxel Stop the Growth of TNBC Patient‐Derived Xenografts and Diminish Tumorigenesis A Sulaiman, S McGarry, S El‐Sahli, L Li, J Chambers, A Phan, E Al‐Kadi, ... Advanced Therapeutics 3 (11), 2000123, 2020 | 1 | 2020 |
| Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model K Mediratta, S El-Sahli, M Marotel, MZ Awan, M Kirkby, A Salkini, ... Frontiers in Immunology 15, 1366197, 2024 | | 2024 |
| The Importance of Context in Inert Gas Asphyxiation Deaths: An Autopsy Case Report T Gelman, A Sulaiman, C James, D Peterson Preprints, 2023 | | 2023 |
| Fatal Hemopericardium due to Rupture of the Ascending Aortic Artery in a Patient with Turner Syndrome: A Case Report with Autopsy Findings A Sulaiman, T Gelman, C James, D Peterson Preprints, 2023 | | 2023 |
| Inhibition of the TGF-beta Pathway Enhances the Tumoricidal Effect of Doxorubicin on Breast Cancer Cells A Sulaiman, S Chilumula, S Tao, M Cobb, E Konorev FASEB JOURNAL 35, 2021 | | 2021 |
| New Approaches for the Treatment of Triple Negative Breast Cancer A Sulaiman Université d'Ottawa/University of Ottawa, 2019 | | 2019 |
